GENB
Generate Biomedicines, Inc.
14.00$
+3.1%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 25 | Q2 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | 45.3% | – | |
| – | – | 54.7% | 100.0% | |
| 531.0% | 589.7% | 755.3% | 1,018.8% | |
| 115.1% | 104.1% | 187.2% | 215.4% | |
| 646.1% | 693.8% | 942.2% | 1,234.2% | |
| -546.1% | -593.8% | -887.5% | -1,134.2% | |
| 4.2% | 3.0% | 2.5% | 2.5% | |
| -501.9% | -559.7% | -853.9% | -1,064.3% | |
| – | – | 0.4% | 0.8% | |
| -472.7% | -517.6% | -850.6% | -1,065.2% | |
| -459.0% | -523.9% | -842.2% | -1,010.8% |
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.